We have done a series of webinars in the last months with our partners in the excipients area. They are very interesting with a lot of specialist knowledge included! See here the list of our most watched and important webinars.
Also have a look at our complete overview and the next upcoming webinars.
BASF has developed ZoomLab™, a science-based formulation tool available online 24/7, enabling formulators to instantly predict and optimize starting drug formulations.
Join this webinar to hear experts discuss the science behind ZoomLab™, with a special focus on the newly launched enteric-release coatings module.
In this webcast, experts will review some of these challenges and the science behind ZoomLabTM, an online formulation optimization and prediction tool available to all formulators, to help reduce significant amounts of trial and error during the formulation process.
More and more poorly water-soluble or even water-insoluble drug candidates show up in pharmaceutical development. Achieving a good bioavailability and efficacy requires technical platforms and processes. Solid dispersions and amorphous solid dispersions are well established and proven approaches to overcome the API solubility issue. We did a well-attended live webcast on this topic with the expert Dr. Norbert Pöllinger from Glatt Pharmaceutical Services. He presented Glatt’s tools and technology platforms and answered a lot of questions related to amorphous solid dispersion.
In the webinar, we discussed conventional in-house preparations as well as ready-to-use systems for solid oral dosage forms. And we will show you which process steps you can optimize when using ready-to-use systems.
Multiparticulates such as micropellets, pellets, granules and mini-tablets represent modern and innovative technology platforms. Multiparticulates can provide a number of advantages compared with larger-sized monolithic forms such as tablets. Increasing compliance is achieved for children – from birth to adolescence – and elderly. Individually tailored drug release profiles for any API and site specific drug delivery allow for an optimized and safe therapeutic effect.
Multiparticulates such as micropellets, pellets, granules and mini-tablets represent modern and innovative technology platforms. Multiparticulates can provide a number of advantages compared with larger-sized monolithic forms such as tablets. Increasing compliance is achieved for children – from birth to adolescence – and elderly. Individually tailored drug release profiles for any API and site specific drug delivery allow for an optimized and safe therapeutic effect.
Multiparticulates such as micropellets, pellets, granules and mini-tablets represent modern and innovative technology platforms. Multiparticulates can provide a number of advantages compared with larger-sized monolithic forms such as tablets. Increasing compliance is achieved for children – from birth to adolescence – and elderly. Individually tailored drug release profiles for any API and site specific drug delivery allow for an optimized and safe therapeutic effect.
Orally Disintegrating Tablets (ODTs) are getting increasingly interesting delivery systems in the pharmaceutical and nutraceutical fields. They are an innovative way to handle the product lifecycle management, generate market differentiation, and increase the interest of consumers. This webinar will provide you with important information to overcome the main challenges during the development of your ODT product.
Starter Pellets are widely used for the formulation and manufacturing of multiparticulates. The characteristics of such pellets can play a vital role in development, scale up an manufacturing.
The webinar aims to cover those topics by example of CELLETS as a neutral starter pellet and TAP as a functional starter pellet.
What is important for a successful tableting formulation? What is the interaction between fillers, flow agents and binders? We consider the necessary excipients that are needed for direct tableting. Among other things, we look at the properties of fillers and dry binders in detail and investigate how the use of excipient premixes can positive influence the tableting process and final product.
The live webcast covers:
– Polymers for direct compression
– Dry binder premixes
– Case studies
– Complete tableting premixes
– Sustained release systems
– Q&A during the webcast
See our recording of the webcast ‘Market Trends & Clean Label Solutions for Solid Oral Dosage Forms‘ to find out, what challenges brand owner & contract manufacturing organizations (CMO) have when they need to develop Clean Label formulations/products.
The recording covers:
– Market trends
– Clean label definition
– Critical excipients in our industry (TiO2, SiO2, synthetic colors etc.)
– New ingredients for reformulation
Qualit-e offers an innovative way to securely upload and share quality documents dramatically reducing time and workload. We did a short interview and a webcast with the founder of Qualit-e Cloud, Nadine Blaettler. You find the interview and the frequently asked questions here. You can view the full webcast.
If you’re not too sure what lipid excipients are in terms of chemistry, functionality, how they solubilize API and the keys steps in formulating a SEDDS or SMEDDS then this presentation is a perfect introduction for you.
